Page last updated: 2024-10-27

furosemide and Familial Hyperpotassemia and Hypertension

furosemide has been researched along with Familial Hyperpotassemia and Hypertension in 5 studies

Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"The conditions were consistent with Type II pseudohypoaldosteronism (PHA)."5.30Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II. ( Corapçioğlu, D; Erdoğan, G; Erdoğan, MF; Hallioğlu, J; Uysal, AR, 1997)
" The dosage of cation exchange resins was decreased, oral fluids were tolerated, and the patient's general condition improved."5.29Effect of hydrochlorothiazide in pseudohypoaldosteronism with hypercalciuria and severe hyperkalemia. ( Rosa, FC; Stone, RC; Vale, P, 1996)
"The conditions were consistent with Type II pseudohypoaldosteronism (PHA)."1.30Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II. ( Corapçioğlu, D; Erdoğan, G; Erdoğan, MF; Hallioğlu, J; Uysal, AR, 1997)
" The dosage of cation exchange resins was decreased, oral fluids were tolerated, and the patient's general condition improved."1.29Effect of hydrochlorothiazide in pseudohypoaldosteronism with hypercalciuria and severe hyperkalemia. ( Rosa, FC; Stone, RC; Vale, P, 1996)
"In adults, persistent hyperkalemic distal renal tubular acidosis in the absence of impaired renal function is an unusual abnormality usually associated with the syndromes of aldosterone deficiency or resistance."1.29Pseudohypoaldosteronism with normal blood pressure. ( Laxdal, V; Morris, G; Shoker, A; Skomro, R, 1996)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castañeda-Bueno, M1
Arroyo, JP1
Zhang, J1
Puthumana, J1
Yarborough, O1
Shibata, S1
Rojas-Vega, L1
Gamba, G1
Rinehart, J1
Lifton, RP1
Stone, RC1
Vale, P1
Rosa, FC1
Shoker, A1
Morris, G1
Skomro, R1
Laxdal, V1
Kuhnle, U1
Hinkel, GK1
Hubl, W1
Reichelt, T1
Erdoğan, G1
Corapçioğlu, D1
Erdoğan, MF1
Hallioğlu, J1
Uysal, AR1

Other Studies

5 other studies available for furosemide and Familial Hyperpotassemia and Hypertension

ArticleYear
Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 01-31, Volume: 114, Issue:5

    Topics: Angiotensin II; Animals; Blood Volume; Chlorocebus aethiops; COS Cells; Cyclic AMP-Dependent Protein

2017
Effect of hydrochlorothiazide in pseudohypoaldosteronism with hypercalciuria and severe hyperkalemia.
    Pediatric nephrology (Berlin, Germany), 1996, Volume: 10, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium; Diuretics; Female; Furosemide; Humans; Hydrochloro

1996
Pseudohypoaldosteronism with normal blood pressure.
    Clinical nephrology, 1996, Volume: 46, Issue:2

    Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Bicarbonates; Blood Pressure; Chlorides; Diuretics; Fem

1996
Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system.
    Hormone research, 1996, Volume: 46, Issue:3

    Topics: Adolescent; Adult; Aldosterone; Case-Control Studies; Child; Child, Preschool; Female; Furosemide; G

1996
Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II.
    Journal of endocrinological investigation, 1997, Volume: 20, Issue:11

    Topics: Adult; Deamino Arginine Vasopressin; Diuretics; Follow-Up Studies; Furosemide; Humans; Male; Pseudoh

1997